1. Zhang, Hao, Zhai, Xiangyu, Liu, Yanfeng, Jin, Bin, Guo, Deliang. 2023. NOP2-mediated m5C Modification of c-Myc in an EIF3A-Dependent Manner to Reprogram Glucose Metabolism and Promote Hepatocellular Carcinoma Progression. In Research (Washington, D.C.), 6, 0184. doi:10.34133/research.0184. https://pubmed.ncbi.nlm.nih.gov/37398932/
2. Delaunay, Sylvain, Pascual, Gloria, Feng, Bohai, Benitah, Salvador Aznar, Frye, Michaela. 2022. Mitochondrial RNA modifications shape metabolic plasticity in metastasis. In Nature, 607, 593-603. doi:10.1038/s41586-022-04898-5. https://pubmed.ncbi.nlm.nih.gov/35768510/
3. Wang, Yueqin, Wei, Jingyao, Feng, Luyao, Kan, Quancheng, Tian, Xin. 2023. Aberrant m5C hypermethylation mediates intrinsic resistance to gefitinib through NSUN2/YBX1/QSOX1 axis in EGFR-mutant non-small-cell lung cancer. In Molecular cancer, 22, 81. doi:10.1186/s12943-023-01780-4. https://pubmed.ncbi.nlm.nih.gov/37161388/
4. Liu, Liwen, Chen, Yu, Zhang, Tao, Xue, Wenhua, Sun, Ranran. 2024. [Not Available]. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2302379. doi:10.1002/advs.202302379. https://pubmed.ncbi.nlm.nih.gov/38566431/
5. Bohnsack, Katherine E, Höbartner, Claudia, Bohnsack, Markus T. 2019. Eukaryotic 5-methylcytosine (m⁵C) RNA Methyltransferases: Mechanisms, Cellular Functions, and Links to Disease. In Genes, 10, . doi:10.3390/genes10020102. https://pubmed.ncbi.nlm.nih.gov/30704115/
6. Tian, Junjie, Gao, Jianguo, Cheng, Cheng, Fu, Guanghou, Jin, Baiye. 2024. NOP2-mediated 5-methylcytosine modification of APOL1 messenger RNA activates PI3K-Akt and facilitates clear cell renal cell carcinoma progression. In International journal of biological sciences, 20, 4853-4871. doi:10.7150/ijbs.97503. https://pubmed.ncbi.nlm.nih.gov/39309431/
智鼠故事 
